FASN and breast carcinoma: We evaluated FASN protein expression in an HRG-overexpressing model of biologically aggressive, endocrine-resistant ER+ breast cancer developed in our laboratory by transducing MCF-7 breast cancer cells with a retroviral vector containing the HRG cDNA (MCF-7/HRG cells [18]).